Pfizer has agreed to a $44 million settlement over allegations that its smoking cessation drug Chantix contained an undisclosed nitrosamine impurity. The claim deadline was September 14, 2026. Here is what the settlement actually covers, who qualified, and what happens between now and payment.
Chantix Settlement Quick Facts
| Detail | Information |
| Settlement fund | $44,000,000 |
| Case | In re Chantix (Varenicline) Mktg., Sales Pracs. & Prods. Liab. Litig. (No. II), 22-MD-3050 |
| Court | U.S. District Court, Southern District of New York |
| Class period | Retail Chantix purchases, September 29, 2015 through September 17, 2021 |
| Claim / opt out / objection deadline | Closed, September 14, 2026 |
| Final approval hearing | October 13, 2026, 3:00 p.m. |
| Payment structure | Pro rata, capped at 20% of the fund for the consumer pool |
| Administrator | A.B. Data, Ltd., 1-877-354-3912 |
What Is the Chantix Settlement About?
Chantix, known generically as varenicline, is a prescription medication Pfizer manufactures to help adults quit smoking. In 2021, Pfizer recalled all lots of Chantix after tablets were found to contain N-nitroso-varenicline, a nitrosamine impurity classified as a probable human carcinogen, above the company’s acceptable intake limit.
The resulting lawsuits, consolidated into multidistrict litigation in the Southern District of New York, alleged that Pfizer fell short of current Good Manufacturing Practices in making Chantix, and that this failure led to the contamination. Pfizer denies any wrongdoing and has not been found liable. The settlement resolves the economic loss claims brought by consumers and third-party payors, meaning claims about money spent on the drug, not personal injury claims for anyone who believes the contamination caused them physical harm.
If you believe you were physically harmed by contaminated Chantix, that is a separate matter from this economic loss settlement and would generally require its own legal claim.
Who Was Covered by the Settlement?
The settlement class included all individuals and third-party payors who paid any amount of money for retail purchases of Chantix in the United States and its territories between September 29, 2015 and September 17, 2021. This covers people who paid out of pocket as well as insurers and other payors who covered part of the cost.
How Much Could Claimants Receive?
Payment to consumer class members is calculated on a pro rata basis according to how much each person paid for Chantix, and the total paid to the consumer pool is capped at 20 percent of the available settlement fund. No consumer’s payment can exceed the total amount they actually paid for the drug. After consumer claims are paid, the remaining fund is distributed to third-party payor class members on a pro rata basis according to their documented payments.
The official claim form asked claimants to state how much they paid and, where possible, include supporting documentation, though it was not framed as a strict requirement the way some other settlements handle documented losses. If you filed a claim and kept your pharmacy records, hold onto them in case the administrator requests verification.
For a general explanation of how pro rata payments work across settlement types, see our guide on how class action payouts are calculated.
The Claim Deadline Has Passed
Unlike some settlements that separate the opt out, objection and claim deadlines, this settlement used a single date, September 14, 2026, for all three. If you did not submit a Claim Form, an exclusion request or an objection by that date, none of those options remain available through the general process.
What Happens Next
The Final Approval Hearing is scheduled for October 13, 2026 at 3:00 p.m. in Courtroom 618 of the Southern District of New York, before Judge Katherine Polk Failla. The court will decide whether to approve the settlement and the attorneys’ fee request, which class counsel has said will not exceed one third of the settlement fund plus costs and expenses. Payments will not be distributed until the settlement receives final approval and any appeals are resolved.
Our guide on how long it takes to get paid after a class action settlement covers why this stage often takes the longest.
Is the Chantix Settlement Legitimate?
Yes. This is part of a real, consolidated federal case, and the only official settlement website is chantixsettlement.com, administered by A.B. Data under court supervision. Because this settlement involves a medication and a carcinogen scare, be alert for scam messages that try to add urgency by referencing health risks. A legitimate update about your claim will come from the settlement administrator, not an unsolicited call demanding immediate payment or personal medical information.
See our guide on class action settlement scams for how to tell the difference.
Separately, this settlement is not medical advice. Do not stop taking a prescribed medication because of a class action lawsuit; talk to your doctor about any concerns regarding Chantix or varenicline.
Chantix Settlement Timeline
| Date | Event |
| 2021 | Pfizer recalls all lots of Chantix over nitrosamine contamination |
| December 22, 2022 | Cases consolidated into MDL No. 3050 |
| March 2026 | Settlement agreement reached |
| June 1, 2026 | Preliminary approval granted |
| September 14, 2026 | Claim, opt out and objection deadline |
| October 13, 2026 | Final Approval Hearing, 3:00 p.m. |
Frequently Asked Questions
Can I still file a Chantix settlement claim?
No. The deadline to submit a claim, opt out or object was September 14, 2026, and has passed.
Do I need a receipt to file a Chantix claim?
The claim form asked claimants to include supporting documentation where possible, but it was not strictly required the way some documented-loss tiers in other settlements work. If you filed and kept pharmacy or purchase records, retain them in case they are requested.
How much will I receive from the Chantix settlement?
Payment is pro rata based on how much you paid for Chantix, with the total consumer pool capped at 20 percent of the available fund. No official per-person figure has been announced.
Is the Chantix nitrosamine settlement the same as a personal injury claim?
No. This settlement resolves economic loss claims, meaning money spent on the drug. A claim that you were physically harmed by the contamination would be a separate legal matter.
When is the Chantix final approval hearing?
October 13, 2026, at 3:00 p.m., in the U.S. District Court for the Southern District of New York.
Is chantixsettlement.com the official website?
Yes. It is the only authorized website for this case, administered by A.B. Data, Ltd.
Bottom Line
The Chantix nitrosamine settlement is now closed to new claims, opt outs and objections. The case moves to a Final Approval Hearing on October 13, 2026, and any payment will follow only after the court approves the settlement and resolves any appeals.
This article is for general information only and is not legal or medical advice. Settlement terms and deadlines are set by the court and the claims administrator and can change. Always verify current details on the official settlement website before acting, and consult your doctor about any medication concerns.
